» Articles » PMID: 28167546

Intracellular Targeting Mechanisms by Antimicrobial Peptides

Overview
Specialty Pharmacology
Date 2017 Feb 8
PMID 28167546
Citations 215
Authors
Affiliations
Soon will be listed here.
Abstract

Antimicrobial peptides (AMPs) are expressed in various living organisms as first-line host defenses against potential harmful encounters in their surroundings. AMPs are short polycationic peptides exhibiting various antimicrobial activities. The principal antibacterial activity is attributed to the membrane-lytic mechanism which directly interferes with the integrity of the bacterial cell membrane and cell wall. In addition, a number of AMPs form a transmembrane channel in the membrane by self-aggregation or polymerization, leading to cytoplasm leakage and cell death. However, an increasing body of evidence has demonstrated that AMPs are able to exert intracellular inhibitory activities as the primary or supportive mechanisms to achieve efficient killing. In this review, we focus on the major intracellular targeting activities reported in AMPs, which include nucleic acids and protein biosynthesis and protein-folding, protease, cell division, cell wall biosynthesis, and lipopolysaccharide inhibition. These multifunctional AMPs could serve as the potential lead peptides for the future development of novel antibacterial agents with improved therapeutic profiles.

Citing Articles

Antimicrobial peptide biological activity, delivery systems and clinical translation status and challenges.

Zheng S, Tu Y, Li B, Qu G, Li A, Peng X J Transl Med. 2025; 23(1):292.

PMID: 40055730 PMC: 11887333. DOI: 10.1186/s12967-025-06321-9.


A New Insight into Phage Combination Therapeutic Approaches Against Drug-Resistant Mixed Bacterial Infections.

Rahimian M, Jafari-Gharabaghlou D, Mohammadi E, Zarghami N Phage (New Rochelle). 2025; 5(4):203-222.

PMID: 40045937 PMC: 11876824. DOI: 10.1089/phage.2024.0011.


Advancing Nanotechnology: Targeting Biofilm-Forming Bacteria with Antimicrobial Peptides.

Campos J, Pontes J, Canales C, Roque-Borda C, Pavan F BME Front. 2025; 6:0104.

PMID: 40041091 PMC: 11876546. DOI: 10.34133/bmef.0104.


Deciphering optimal molecular determinants of non-hemolytic, cell-penetrating antimicrobial peptides through bioinformatics and Random Forest.

Kumar A, Chadha S, Sharma M, Kumar M Brief Bioinform. 2025; 26(1).

PMID: 39973083 PMC: 11839508. DOI: 10.1093/bib/bbaf049.


Septic arthritis - symptoms, diagnosis and new therapy.

Domagala A, Macura B, Piekarz K, Kiecka A Eur J Clin Microbiol Infect Dis. 2025; .

PMID: 39964630 DOI: 10.1007/s10096-025-05066-z.


References
1.
Kruszewska D, Sahl H, Bierbaum G, Pag U, Hynes S, Ljungh A . Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J Antimicrob Chemother. 2004; 54(3):648-53. DOI: 10.1093/jac/dkh387. View

2.
Lutkenhaus J . Regulation of cell division in E. coli. Trends Genet. 1990; 6(1):22-5. DOI: 10.1016/0168-9525(90)90045-8. View

3.
Le C, Mohd Yusof M, Abdulla Hassan M, Lee V, Isa D, Sekaran S . In vivo efficacy and molecular docking of designed peptide that exhibits potent antipneumococcal activity and synergises in combination with penicillin. Sci Rep. 2015; 5:11886. PMC: 4496672. DOI: 10.1038/srep11886. View

4.
Forssten S, Bjorklund M, Ouwehand A . Streptococcus mutans, caries and simulation models. Nutrients. 2012; 2(3):290-8. PMC: 3257652. DOI: 10.3390/nu2030290. View

5.
Hasper H, Kramer N, Smith J, Hillman J, Zachariah C, Kuipers O . An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science. 2006; 313(5793):1636-7. DOI: 10.1126/science.1129818. View